Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › NEAT1 as a prognostic marker and therapeutic target for prostate cancer

NEAT1 as a prognostic marker and therapeutic target for prostate cancer

US Patent 10294476 · Granted May 21, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Image acquisition methods for simultaneously detecting genetic rearrangement and2022
Recurrent SPOP mutations in prostate cancer2019
Recurrent gene fusions in prostate cancer2019
Spectral imaging for measurement of nuclear pathology features in cancer cells p2018
Systems and methods to control the lifetime of online posts2018
Recurrent gene fusions in prostate cancer2017
ERG/TFF3/HMWCK triple immunostain for detection of prostate cancer2017
Molecular subtyping, prognosis and treatment of prostate cancer2017
Compositions and methods for diagnosing prostate cancer based on detection of SL2016
Recurrent gene fusions in prostate cancer2016
Methods of diagnosing and treating prostate cancer characterized by NDRG1-ERG fu2015
Recurrent gene fusions in prostate cancer2015